Article Versions Notes

Kim S, Lee H, Moon H, Kim R, Kim M, Jeong S, Kim H, Kim SH, Hwang SS, Lee MY, et al. Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition. Antioxidants. 2023; 12(5):1059. https://doi.org/10.3390/antiox12051059

Kim, Sejin, Hyunjae Lee, Hanbyeol Moon, Ran Kim, Minsuk Kim, Seongtae Jeong, Hojin Kim, Sang Hyeon Kim, Soo Seok Hwang, Min Young Lee, and et al. 2023. "Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition" Antioxidants 12, no. 5: 1059. https://doi.org/10.3390/antiox12051059

Kim, S., Lee, H., Moon, H., Kim, R., Kim, M., Jeong, S., Kim, H., Kim, S. H., Hwang, S. S., Lee, M. Y., Kim, J., Song, B.-W., & Chang, W. (2023). Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition. Antioxidants, 12(5), 1059. https://doi.org/10.3390/antiox12051059